<DOC>
	<DOCNO>NCT00915837</DOCNO>
	<brief_summary>This Phase 1 study evaluate safety , tolerability duration effect helical intravitreal triamcinolone implant treatment diabetic macular edema three-year period .</brief_summary>
	<brief_title>Safety Tolerability Study Helical Intravitreal Triamcinolone Implant Diabetic Macular Edema</brief_title>
	<detailed_description>The Helical Intravitreal Triamcinolone Implant intend provide sustain release triamcinolone acetonide vitreous chamber eye .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Patients clinically observable macular edema associate diabetic retinopathy study eye Macular edema study eye associate 1. visual acuity 20/40 worse ; 2. retinal thicken fovea see biomicroscopic examination 3. angiographic evidence leakage involve perifoveal capillary net Failure macular edema improve prior macular photocoagulation , patient unlikely benefit macular photocoagulation opinion investigator Patients must 18 year age old Patients must willing able return schedule follow examination 3 year initial surgery . Patients must sign give copy write Informed Consent form . Monocular , vision worse 20/400 fellow eye Visual acuity worse 20/200 20/200 &lt; 34 letter read study eye Use depot periocular steroid study eye within past 30 day Current use &gt; 15 mg/day oral steroid Known steroid responder Ocular hypertension &gt; 22 mmHg study eye need one medication maintain IOP &lt; 22 mmHg . Cup disc ratio &gt; 0.8 study eye Prior filtration surgery glaucoma implant surgery study eye Any active ocular infection either eye History herpetic ocular infection study eye Macular ischemia , define angiographic evidence enlargement foveal avascular zone 1 disc area large , center fovea Macular panretinal photocoagulation treatment study eye within past 90 day ; laser capsulotomy within past 90 day Planned know need ocular surgery study eye within 90 day enrollment treatment Any condition precludes subject 's ability comply study requirement , include examination completion study ; condition preclude examiner 's ability obtain reliable fundus photography , angiography , OCT image Females pregnant lactating , premenopausal female unwilling use medically accept method birth control duration study Participation another investigational trial within 30 day prior enrollment study period Uncontrolled hypertension ( systolic BP &gt; 160 mm Hg and/or diastolic BP &gt; 90 mmHg ) Uncontrolled diabetes ( HbA1c &gt; 13 ) Chronic renal failure require dialysis anticipate renal transplant Retinal choroidal neovascularization study eye ; anticipate need panretinal photocoagulation within next 30 day Macular edema study eye know due cause diabetic retinopathy Use immunosuppressant drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>DME</keyword>
</DOC>